Compositions comprising the Tbp2 subunit of the transferrin receptor of Neisseria meningitidis
AssigneesPasteur Merieux Serums et Vaccins, Transgene S.A.
InventorsEric Jacobs, Michele Legrain, Veronique Mazarin, Bernadette Bouchon-Theisen, Anthony B. Schryvers, Marie-Aline Bloch
Life of this patent
Estimating the term…
Abstract
The subject of the present invention is a DNA fragment which encodes a protein capable of being recognised by an antiserum against the transferrin receptor of the strain IM2394 or IM2169 of N. meningitidis as well as a process for producing the said protein by a recombinant route. By way of example, such a DNA fragment encodes the tbp1 subunit of the strain IM2394 or IM2169 or the tbp2 subunit of the strain IM2394 or IM2169.
Claims8
A composition of matter comprising two proteins and a carrier therefor, wherein said proteins are recognized by an antiserum against the transferrin receptor of the strain IM2394 or IM2169 of N. meningitidis, wherein said proteins are obtained by
- culturing a host cell transformed by an expression cassette which comprises a DNA sequence which encodes the amino acid sequence of SEQ ID NO:
- 2, from position -20 to position 579;
- and further comprises a DNA sequence which encodes the amino acid sequence of SEQ ID NO:
- 8, from position -20 to position 691;
- further wherein said expression cassette does not comprise the DNA sequence encoding the amino acid sequence of SEQ ID NO:
- 4, from position -24 to position 884, nor the DNA sequence encoding the amino acid sequence of SEQ ID NO:
- 6 from position -24 to position 887;
- said DNA sequences being placed under the control of elements required for their expression;
- and
- recovering the proteins from the culture.
A composition of matter comprising two proteins and a carrier therefor, wherein said proteins are recognized by an antiserum against the transferrin receptor of the strain IM2394 or IM2169 of N. meningitides, wherein said proteins are obtained by
- culturing a host cell transformed by an expression cassette which comprises a DNA sequence which encodes the amino acid sequence of SEQ ID NO:
- 2, from position 1 to position 579;
- and further comprises a DNA sequence which encodes the amino acid sequence of SEQ ID NO:
- 8, from position 1 to position 691;
- further wherein said expression cassette does not comprise the DNA sequence encoding the amino acid sequence of SEQ ID NO:
- 4, from position 1 to position 884, nor the DNA sequence encoding the amino acid sequence of SEQ ID NO:
- 6 from position 1 to position 887;
- said DNA sequences being placed under the control of elements required for their expression;
- and
- recovering the proteins from the culture.
A composition of matter comprising a protein and a carrier therefor, wherein said protein is recognized by an antiserum against the transferrin receptor of the strain IM2394 or IM2169 of N. meningitidis, and further wherein said protein is obtained by
- culturing a host cell transformed by an expression cassette which comprises a DNA sequence which encodes the Tbp2 subunit of N. meningitidis, and does not encode the Tbp1 subunit, wherein said Tbp2 subunit has an amino acid sequence selected from the group consisting of:
- SEQ ID NO:
- 2, from position -20 to position 579;
- and
- SEQ ID NO:
- 8, from position -20 to position 691,
- said DNA sequence being placed under the control of the elements required for its expression;
- and
- recovering the protein from the culture.
A composition of matter comprising a protein and a carrier therefor, wherein said protein is recognized by an antiserum against the transferrin receptor of the strain IM2394 or IM2169 of N. meningitidis, and further wherein said protein is obtained by:
- culturing a host cell transformed by an expression cassette which comprises a DNA sequence which encodes the Tbp2 subunit of N. meningitidis, and does not encode the Tbp1 subunit, wherein said Tbp2 subunit has an amino acid sequence selected from the group consisting of:
- SEQ ID NO:
- 2, from position 1 to position 579;
- and
- SEQ ID NO:
- 8, from position 1 to position 691,
- said DNA sequence being placed under the control of the elements required for its expression;
- and
- recovering the protein from the culture.
A pharmaceutical composition comprising as an active ingredient two proteins capable of being recognized by an antiserum against the transferrin receptor of the strain IM2394 or IM2169 of N. meningitidis, and a carrier therefor, wherein said proteins are obtained by
- culturing a host cell transformed by an expression cassette which comprises a DNA sequence which encodes the amino acid sequence of SEQ ID NO:
- 2, from position -20 to position 579;
- and further comprises a DNA sequence which encodes the amino acid sequence of SEQ ID NO:
- 8, from position -20 to position 691;
- further wherein said expression cassette does not comprise the DNA sequence encoding the amino acid sequence of SEQ ID NO:
- 4, from position -24 to position 884, nor the DNA sequence encoding the amino acid sequence of SEQ ID NO:
- 6 from position -24 to position 887;
- said DNA sequences being placed under the control of elements required for its expression;
- and recovering the proteins from the culture.
A pharmaceutical composition comprising as an active ingredient two proteins capable of being recognized by an antiserum against the transferrin receptor of the strain IM2394 or IM2169 of N. meningitides, and a carrier therefor, wherein said proteins are obtained by
- culturing a host cell transformed by an expression cassette which comprises a DNA sequence which encodes the amino acid sequence of SEQ ID NO:
- 2, from position 1 to position 579;
- and further comprises a DNA sequence which encodes the amino acid sequence of SEQ ID NO:
- 8, from position 1 to position 691;
- further wherein said expression cassette does not comprise the DNA sequence encoding the amino acid sequence of SEQ ID NO:
- 4, from position 1 to position 884, nor the DNA sequence encoding the amino acid sequence of SEQ ID NO:
- 6 from position 1 to position 887;
- said DNA sequences being placed under the control of elements required for its expression;
- and recovering the proteins from the culture.
A pharmaceutical composition comprising as an active ingredient a protein capable of being recognized by an antiserum against the transferrin receptor of the strain IM2394 or IM2169 of N. meningitidis and a carrier therefor, wherein said protein is obtained by culturing a host cell transformed by an expression cassette which comprises a DNA sequence which encodes the Tbp2 subunit of N. meningitidis, and does not encode the Tbp1 subunit, wherein said Tbp2 subunit has an amino acid sequence selected from the group consisting of:
- SEQ ID NO:
- 2, from position -20 to position 579;
- and
- SEQ ID NO:
- 8, from position -20 to position 691,
- said DNA sequence being placed under the control of the elements required for its expression;
- and recovering the protein from the culture.
A pharmaceutical composition comprising as an active ingredient a protein capable of being recognized by an antiserum against the transferrin receptor of the strain IM2394 or IM2169 of N. meningitidis, and a carrier therefor, wherein said protein is obtained by
- culturing a host cell transformed by an expression cassette which comprises a DNA sequence which encodes the Tbp2 subunit of N. meningitidis, and does not encode the Tbp1 subunit, wherein said Tbp2 subunit has an amino acid sequence selected from the group consisting of:
- SEQ ID NO:
- 2, from position 1 to position 579;
- and
- SEQ ID NO:
- 8, from position 1 to position 691,
- said DNA sequence being placed under the control of the elements required for its expression;
- and recovering the protein from the culture.
Dependencies are inferred from the claim text.